Bank Of Montreal Hutchmed (China) LTD Transaction History

Bank Of Montreal

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$8.59 - $20.77 $102,650 - $248,201	-11,950 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$15.52 - $35.65 $2,684 - $6,167	173 Added 1.47%	11,950 $239,000
Q4 2021 Feb 11, 2022	BUY	$28.89 - $35.33 $151,152 - $184,846	5,232 Added 79.94%	11,777 $419,000
Q2 2021 Aug 12, 2021	BUY	$23.7 - $39.27 $155,116 - $257,022	6,545 New	6,545 $218,000

8.25M

3.8K

2.4K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.29B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.